Kitsa’s AI Streamlines Clinical Trial Site Selection
The clinical trial industry traditionally grapples with significant bottlenecks in site selection, primarily due to fragmented data, manual processes, and reliance on personal networks. Kitsa, a health-tech company specializing in AI-driven solutions, has addressed this challenge by implementing Amazon Quick Automate, a generative AI-powered workflow automation capability of Amazon Quick Suite. This technology enables Kitsa to build a scalable, secure, and compliant data pipeline that transforms site selection from a slow, relationship-driven process into a fast, data-driven system.
Kitsa’s solution leverages Quick Automate’s advanced multi-agent automation architecture, which integrates UI automation, API integrations, and workflow orchestration. A critical component is the UI Agent, configured to autonomously navigate websites and extract over 50 distinct data points using natural language instructions, delivering structured outputs. The workflow incorporates parallel processing for efficiency, intelligent data extraction with AI reasoning, and a human-in-the-loop (HILO) mechanism to ensure data quality for low-confidence extractions. Data is persistently stored in Excel and Amazon S3, with robust exception handling for operational continuity.
This implementation has yielded remarkable results for Kitsa: a 91% reduction in operational costs, a 96% acceleration in data acquisition (processing in days what previously took months), and 96% coverage in data extraction across hundreds of thousands of websites, all while maintaining full regulatory compliance. Kitsa’s Site Finder Agent now objectively evaluates numerous site-specific parameters, empowering clinical trial sponsors with evidence-based decisions and allowing capable research sites to effectively showcase their capabilities.
Kitsa’s innovative ai automation clinical platform revolutionizes how pharmaceutical companies identify and evaluate potential research sites for their studies.
While many companies explore chatgpt automation clinical applications, Kitsa’s specialized AI focuses specifically on optimizing the complex process of clinical trial site selection.
